Patents by Inventor Eyal Gilboa

Eyal Gilboa has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20120010735
    Abstract: A device forming an earpiece is provided. The device includes a member generally shaped to fit within an ear of a person. The device further includes an adhesive coupled to the member, such that the adhesive is separable from the member. In addition, the adhesive is adapted to adhere the member to the ear.
    Type: Application
    Filed: July 9, 2010
    Publication date: January 12, 2012
    Inventor: Eyal Gilboa
  • Publication number: 20100184987
    Abstract: Provided are processes for preparation of Retapamulin via its pleuromutilin-thiol precursor.
    Type: Application
    Filed: November 12, 2009
    Publication date: July 22, 2010
    Inventors: Nimer Jaber, Lilach Hedvati, Eyal Gilboa, Sharon Avhar-Maydan
  • Publication number: 20100010221
    Abstract: Processes for purifying Varenicline base or the L-tartrate salt thereof and for preparing Varenicline L-tartrate crystalline forms A and B are provided.
    Type: Application
    Filed: May 28, 2009
    Publication date: January 14, 2010
    Inventors: Revital Lifshitz-Liron, Shalom Shabat, Sharon Tomer, Yuriy Raizi, Eyal Gilboa, Pramod Kumar Pandey
  • Publication number: 20090149655
    Abstract: Processes for preparing tropine derivatives of the following Formula B are provided where LG represents a leaving group. The tropine derivatives may be used to prepare Retapamulin, preferably in substantially pure form.
    Type: Application
    Filed: December 5, 2008
    Publication date: June 11, 2009
    Inventors: Lilach Hedvati, Eyal Gilboa, Sharon Avhar-Maydan, Sharona Shachan-Tov
  • Publication number: 20090124814
    Abstract: Provided are processes for preparing telmisartan-alkyl ester and telmisartan using environmentally friendly organic solvents that are easily removed from the reaction mixture, wherein a telmisartan alkyl ester is isolated and hydrolyzed to form telmisartan or the telmisartan is prepared using a synthesis in a single reaction vessel.
    Type: Application
    Filed: January 12, 2009
    Publication date: May 14, 2009
    Inventors: Nurit Perlman, Eyal Gilboa
  • Patent number: 7501448
    Abstract: Provided are processes for preparing telmisartan alkyl ester and telmisartan using environmentally friendly organic solvents that are easily removed from the reaction mixture, wherein a telmisartan alkyl ester is isolated and hydrolyzed to form telmisartan or the telmisartan is prepared using a synthesis in a single reaction vessel.
    Type: Grant
    Filed: October 13, 2005
    Date of Patent: March 10, 2009
    Assignee: Teva Pharmaceutical Industries, Ltd.
    Inventors: Nurit Perlman, Eyal Gilboa
  • Patent number: 7462738
    Abstract: Provided are processes for the synthesis of R-(+)-3-(carbamoylmethyl)-5-methylhexanoic acid and salts thereof, intermediates in the synthesis of S-pregabalin.
    Type: Grant
    Filed: May 24, 2007
    Date of Patent: December 9, 2008
    Assignee: Teva Pharmaceutical Industries Ltd.
    Inventors: Lilach Hedvati, Eyal Gilboa, Sharon Avhar-Maydan
  • Publication number: 20080114028
    Abstract: Polymorphic forms of solifenacin have been prepared and characterized. These polymorphic forms are particularly useful in pharmaceutical compositions.
    Type: Application
    Filed: July 24, 2007
    Publication date: May 15, 2008
    Inventors: Tamas Koltai, Tamar Nidam, Eyal Gilboa, Nurit Perlman, Michael Pinhasov, Mili Abramov
  • Patent number: 7368581
    Abstract: Provided is a process for preparing a polymorphic form of fluvastatin sodium, particularly Form XIV.
    Type: Grant
    Filed: August 17, 2004
    Date of Patent: May 6, 2008
    Assignee: Teva Pharmaceutical Industries Ltd.
    Inventors: Gustavo Frenkel, Eyal Gilboa
  • Publication number: 20080009466
    Abstract: The invention relates to solid crystalline forms of ibandronic acid, pharmaceutical formulations thereof, and methods of treatment therewith.
    Type: Application
    Filed: April 25, 2007
    Publication date: January 10, 2008
    Inventors: Sharon Avhar-Maydan, Eyal Gilboa, Tamas Koltai, Revital Lifshitz-Liron
  • Publication number: 20070293694
    Abstract: Provided are processes for the synthesis of R-(+)-3-(carbamoylmethyl)-5-methylhexanoic acid and salts thereof, intermediates in the synthesis of S-pregabalin.
    Type: Application
    Filed: May 24, 2007
    Publication date: December 20, 2007
    Inventors: Lilach Hedvati, Eyal Gilboa, Sharon Avhar-Maydan
  • Publication number: 20060293377
    Abstract: Provided is the amorphous form of telmisartan sodium and the preparation thereof. Also provided are the telmisartan sodium polymorph crystal Forms 0 to XIII and XV to XX and preparations thereof. Also provided are pharmaceutical composition of amorphous and polymorphic forms of telmisartan sodium or mixtures thereof, and methods of treatment of a mammal in need thereof.
    Type: Application
    Filed: November 3, 2005
    Publication date: December 28, 2006
    Inventors: Shlomit Wizel, Nurit Perlman, Sharon Avhar-Maydan, Eyal Gilboa
  • Publication number: 20060094883
    Abstract: Provided are processes for preparing telmisartan alkyl ester and telmisartan using environmentally friendly organic solvents that are easily removed from the reaction mixture, wherein a telmisartan alkyl ester is isolated and hydrolyzed to form telmisartan or the telmisartan is prepared using a synthesis in a single reaction vessel.
    Type: Application
    Filed: October 13, 2005
    Publication date: May 4, 2006
    Inventors: Nurit Perlman, Eyal Gilboa
  • Publication number: 20050119342
    Abstract: Provided is a process for preparing a polymorphic form of fluvastatin sodium, particularly Form XIV.
    Type: Application
    Filed: August 17, 2004
    Publication date: June 2, 2005
    Inventors: Gustavo Frenkel, Eyal Gilboa